Skip to content
Search for:
The Society
Board of Directors
Scientific Advisory Council
Contact
Events Calendar
Mentor Program
Rare Disease Task Force
BOD Trainee Representatives
Awards & Grants
Local Delivery Grants
Lifetime Achievement Award
Young Investigator Award
Dr. Alan M. Gewirtz Memorial Scholarships
Award for Science Outreach or Patient Advocacy
Paper of the Year Awards
Travel Grants
Poster Awards
Science News
Recent Articles
President’s Pick and Perspective
Journal
Archive
Educational Video Library
Support for Ukrainian Scientists
Job Board
Employer Profiles
Employer Registration / Login
Events
Annual Meetings
2024 Annual Meeting
2023 Annual Meeting
Past Annual Meetings
2022 Annual Meeting
2022 Annual Meeting
Agenda
Abstracts & Awards
Exhibitors
Sponsors
Venue & Travel
2021 Annual Meeting
2020 Annual Meeting
Webinars
Events Calendar
Membership
Become A Member or Renew Membership
Featured Members
Search for:
3′-End labeling of nucleic acids by a polymerase ribozyme
OTS
Ribozyme
June 30, 2018
SHARE
Post Views:
326
Samanta B, Horning DP, Joyce GF.
Nucleic Acids Res. 2018 Jun 13.
PubMed
Previous
Next
Related articles
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
April 23rd, 2021
Hovlinc is a recently evolved class of ribozyme found in human lncRNA
Hovlinc is a recently evolved class of ribozyme found in human lncRNA
April 23rd, 2021
siRNAs containing 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2′-F-NMC NTPs
siRNAs containing 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2′-F-NMC NTPs
March 15th, 2021
Perspectives on the Designation of Oligonucleotide Starting Materials
Perspectives on the Designation of Oligonucleotide Starting Materials
March 15th, 2021
Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs.
Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs.
March 15th, 2021
Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice
Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice
February 16th, 2021
Page load link
Go to Top